Shukun Han

CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis

Chongli Zhong, Lei Fu, Baokang Wu, 2022, Frontiers in Immunology.

Novel immune scoring dynamic nomograms based on B7-H3, B7-H4, and HHLA2: Potential prediction in survival and immunotherapeutic efficacy for gallbladder cancer

Yu Tian, Lei Fu, Feng Xu, 2022, Frontiers in Immunology.

KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy

Yu Tian, Feng Xu, Chongli Zhong, 2022, Journal of advanced research.

Multi-omics profiling and digital image analysis reveal the potential prognostic and immunotherapeutic properties of CD93 in stomach adenocarcinoma

Yang Li, L. Fu, Baokang Wu, 2023, Frontiers in Immunology.

SP1‐induced lncRNA DANCR contributes to proliferation and invasion of ovarian cancer

Yu-juan Zhang, Shukun Han, Peng-Hua Cui, 2020, The Kaohsiung journal of medical sciences.

RETRACTED ARTICLE: Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression

Bing Han, Zhongmin Li, Shukun Han, 2019, Cell cycle.

Expression of tiRNA and tRF in APP/PS1 transgenic mice and the change of related proteins expression

H. Cui, Lin Liu, Lina Ma, 2021, Annals of translational medicine.

Angiogenesis modulated by CD93 and its natural ligands IGFBP7 and MMRN2: a new target to facilitate solid tumor therapy by vasculature normalization

Yu Tian, Chongli Zhong, Yang Yu, 2023, Cancer Cell International.